Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProGen PRP Advantage is an FDA 510(k) cleared medical device system designed for the rapid and efficient preparation of autologous Platelet Rich Plasma (PRP). Developed by Crown Aesthetics, a division of Crown Laboratories, the system utilizes a single-spin centrifugation process with 15mL or 30mL tubes to concentrate a patient's own platelets and plasma from peripheral blood. The resulting PRP contains a high concentration of growth factors, such as PDGF, VEGF, and TGF-β, which are released upon activation to promote tissue repair, collagen synthesis, and angiogenesis. It is primarily indicated for use in aesthetic medicine applications, including facial rejuvenation, skin texture improvement, hair restoration, and the treatment of various forms of alopecia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProGen PRP Advantage.